AU2016904024A0 - Peptide libraries and methods of use - Google Patents

Peptide libraries and methods of use

Info

Publication number
AU2016904024A0
AU2016904024A0 AU2016904024A AU2016904024A AU2016904024A0 AU 2016904024 A0 AU2016904024 A0 AU 2016904024A0 AU 2016904024 A AU2016904024 A AU 2016904024A AU 2016904024 A AU2016904024 A AU 2016904024A AU 2016904024 A0 AU2016904024 A0 AU 2016904024A0
Authority
AU
Australia
Prior art keywords
methods
peptide libraries
libraries
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016904024A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
QIMR Berghofer Medical Research Institute
Original Assignee
Queensland Institute of Medical Research QIMR
Filing date
Publication date
Application filed by Queensland Institute of Medical Research QIMR filed Critical Queensland Institute of Medical Research QIMR
Publication of AU2016904024A0 publication Critical patent/AU2016904024A0/en
Priority to CA3039262A priority Critical patent/CA3039262A1/en
Priority to EP17857697.1A priority patent/EP3523467A4/en
Priority to US16/339,189 priority patent/US20200123198A1/en
Priority to AU2017340028A priority patent/AU2017340028A1/en
Priority to JP2019538546A priority patent/JP2019532103A/en
Priority to PCT/AU2017/051077 priority patent/WO2018064718A1/en
Priority to AU2022218584A priority patent/AU2022218584A1/en
Abandoned legal-status Critical Current

Links

AU2016904024A 2016-10-04 2016-10-04 Peptide libraries and methods of use Abandoned AU2016904024A0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
CA3039262A CA3039262A1 (en) 2016-10-04 2017-10-03 Peptide libraries and methods of use
EP17857697.1A EP3523467A4 (en) 2016-10-04 2017-10-03 Peptide libraries and methods of use
US16/339,189 US20200123198A1 (en) 2016-10-04 2017-10-03 Peptide Libraries and Methods of Use
AU2017340028A AU2017340028A1 (en) 2016-10-04 2017-10-03 Peptide libraries and methods of use
JP2019538546A JP2019532103A (en) 2016-10-04 2017-10-03 Peptide libraries and methods of use
PCT/AU2017/051077 WO2018064718A1 (en) 2016-10-04 2017-10-03 Peptide libraries and methods of use
AU2022218584A AU2022218584A1 (en) 2016-10-04 2022-08-18 Peptide libraries and methods of use

Publications (1)

Publication Number Publication Date
AU2016904024A0 true AU2016904024A0 (en) 2016-10-20

Family

ID=

Similar Documents

Publication Publication Date Title
EP3509615A4 (en) Stable peptides and methods of use thereof
EP3700527A4 (en) Papd5 inhibitors and methods of use thereof
EP3504213A4 (en) Amino-pyrrolopyrimidinone compounds and methods of use thereof
EP3442991A4 (en) Ras binding peptides and methods of use
EP3429635A4 (en) Anti-crispr compounds and methods of use
EP3383430A4 (en) Antibodies and methods of use thereof
EP3510040A4 (en) Ectonucleotidase inhibitors and methods of use thereof
EP3280441A4 (en) Anti-sortilin antibodies and methods of use thereof
EP3245291A4 (en) Novel micro-dystrophins and related methods of use
EP3548033A4 (en) Compounds and their methods of use
EP3589319A4 (en) Glycan-interacting compounds and methods of use
EP3558998A4 (en) Ectonucleotidase inhibitors and methods of use thereof
EP3344803A4 (en) Modular polypeptide libraries and methods of making and using same
EP3240799A4 (en) S-alkylated hepcidin peptides and methods of making and using thereof
EP3595699A4 (en) Cartilage-homing peptide conjugates and methods of use thereof
EP3638290A4 (en) Renal-homing peptide conjugates and methods of use thereof
EP3274472A4 (en) Antimicrobial peptides and methods of use thereof
EP3559042A4 (en) Anti-lilrb3 antibodies and methods of use thereof
EP3389705A4 (en) Listeria-based immunotherapy and methods of use thereof
EP3313865A4 (en) Synthetic peptide compounds and methods of use
EP3541847A4 (en) Glycan-interacting compounds and methods of use
EP3525583A4 (en) Anti-c1s antibodies and methods of use thereof
EP3635000A4 (en) Manabodies and methods of using
EP3688011A4 (en) Peptide compositions and methods of use thereof
EP3710430A4 (en) Acss2 inhibitors and methods of use thereof